Effect of bevacizumab against cystic components of brain tumors

Effect of bevacizumab against cystic components of brain tumors

Abstract Background Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. Materials and Methods Between 2008 and 2018, 13...

Full description

Bibliographic Details
Main Authors: Fumiyuki Yamasaki, Manish Kolakshyapati, Motoki Takano, Ushio Yonezawa, Ikuno Nishibuchi, Nobuki Imano, Akira Taguchi, Shumpei Onishi, Vishwa Jeet Amatya, Yukio Takeshima, Yasushi Nagata, Kaoru Kurisu, Kazuhiko Sugiyama
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Cancer Medicine
Subjects:
bevacizumab
cyst
glioblastoma
metastatic brain tumor
primary brain tumor
Online Access:https://doi.org/10.1002/cam4.2537

Internet

https://doi.org/10.1002/cam4.2537

Similar Items